Current XanaMIA pivotal phase 2/3 trial on track for interim analysis in January 2026 and final results late 2026 with…
SHANGHAI, Sept. 14, 2025 (GLOBE NEWSWIRE) -- At its 10th H2H Healthcare Ecosystem Conference, Fangzhou Inc. (“Fangzhou” or the “Company”)…
TALLMADGE, OH / ACCESS Newswire / September 13, 2025 / Memory Lift is a brain health supplement that is said…
September 12, 2025 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Interim results for the six months ended June 30, 2025 Biodexa…
SACRAMENTO, Calif., Sept. 11, 2025 /PRNewswire/ -- Sophont, a medical AI startup, announced the closing of its $9.22M pre-seed and…
BOULDER, Colo., Sept. 11, 2025 /PRNewswire/ -- Amplifire, a leader in adaptive learning and workforce development, is sharing best practices…
MIXT IV Spa, a Modern Health and Wellness Destination, is Excited to Announce Its Opening in Los Alamitos, Proudly Serving…
MIXT IV Spa, a Modern Health and Wellness Destination, is Excited to Announce Its Opening in Los Alamitos, Proudly Serving…
Prof. Ahmad AbuSalah: KFSHRC’s Sustainable Digital Innovation Ecosystem Features 30+ AI Solutions and 5 New Agents in 2025 Prof. Ahmad…
Marks a significant milestone in ongoing collaboration between RadioMedix and Vect-Horus to advance innovative Theranostic radiopharmaceuticals to address unmet needs…